OptiCept Technologies
1.94 SEK
-0.41 %
Less than 1K followers
OPTI
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for OptiCept Technologies
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.9 | 5.4 | 17.7 | 5.3 | 1.2 | 19.8 | 0.9 | 27.2 |
| EBITDA | -9.9 | -14.9 | -42.5 | -12.4 | -16.0 | 0.1 | -43.7 | -72.1 |
| EBIT | -12.5 | -17.5 | -56.1 | -15.0 | -18.6 | -2.5 | -48.2 | -84.3 |
| EBIT-% | -321.4 % | -325.3 % | -317.4 % | -284.3 % | -1,563.9 % | -12.7 % | -5,186.8 % | -309.6 % |
| Profit before taxes | -13.2 | -17.8 | -55.9 | -16.0 | -19.1 | -4.1 | -51.5 | -90.7 |
| Net income | -13.2 | -17.6 | -55.7 | -16.0 | -19.1 | -4.1 | -51.3 | -90.5 |